The online version of this article (doi:10.1186/1477-7819-10-51) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
BK, PA, PA, FE were the surgical team involved in the management of the patient. ME performed the pathological assessment. BN and MA designed and co-wrote the paper. All authors read and approved the final manuscript.
Serous adenomas represent 1-2% of pancreatic neoplasms and typically are asymptomatic not requiring any treatment and simple observation is the option of choice. Although, they carry a realistic risk of malignancy despite the general view that they never become malignant. We report a case, which, according to our best knowledge is the 27th case reported in the literature.
We reviewed the literature by performing a search in Pub Med and Medline.
A 86-year old patient known to have a serous cystadenoma of the pancreas treated conservatively through a close clinical and radiological follow up which was unattended for 4 years ending up to our emergency department suffering an acute abdomen. Exploratory laparotomy revealed a perforated prepyloric ulcer which was treated accordingly. Patient died some weeks later due to severe medical co morbidities.
Serous cystic neoplasms of the pancreas carry a realistic risk of malignancy despite the general view that they never become malignant. In our opinion the treatment strategy of serous cystic neoplasms of the pancreas should be aggressive even in cases of remote metastases since prognosis of the disease is satisfactory
Horvath K, Charbot JA: An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg. 1999, 178: 262-274. CrossRef
Bosman FT, Carneiro F, Hruban RH, Theise ND: WHO Classification of Tumors of the Digestive System. IARC WHO Classification of Tumors, 3: No3, 4
Compagno J, Oertel JE: Microcystic adenomas of the pancreas(glycogen-rich cystadenomas). Am J Clin Pathol. 1978, 69: 289-298. PubMed
Compagno J, Oertel JE: Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma): A clinicopathological study of 41 cases. Am J Clin Parhol. 1978, 69: 573-580.
Kloppel G, Solcia E, Longnecker DS, Capella C, Sobin LH: Histological typing of tumors of the exocrine pancreas. WHO international histological classification of tumors. 1996, Berlin: Springer, 2
George DH, Murphy F, Michalski R, Ulmer BG: Serous cystadenocarcinoma of the pancreas: A new entity?. 1989, 13: 61-66.
Jonathan King, Tina Ng, Stephen White, Cortina Galen, Howard Reber, Joe Hines O: Pancreatic Serous Cystadenocarcinoma: A case report an review of the literature. J Gastrointest Surg. 2009, 13: 1864-1868. 10.1007/s11605-009-0926-3. CrossRef
Schmidt-Rohlfing B, Siech M, Mattfeldt T, Schoenberg MH, Bager HG: Cystic neoplasms of the pancreas: surgical treatment and outcome. Z Gastroenterol. 1998, 36: 939-945. PubMed
Kimura W, Makuuchi M: Operative indications for cystic lesions of the pancreas with malignant potential: Our experience. Hepatogastroenterology. 1999, 46: 483-491. PubMed
Abe H, Kubota K, Mori M, Miki K, Minagawa M, Noise T, Kimura W, Makuutchi M: Serous cystadenoma of the pancreas with invasive growth: Benign or malignant?. Am J Gastroenterol. 1989, 93: 1963-1966. CrossRef
Verbesey JE, Munson JL: Pancreatic cystic neoplasms. Surg Clin N Am 90. 2010, 411-425.
Federle M, Mc Grath K: Cystic neoplasms of the pancreas. Gastroenterol Clin N Am 36. 2007, 365-376.
Allen PJ, Jaques DP, D'Angelica M, Bowne WB, Conlon KC, Brennan MF: Cystic lesions of the pancreas: selection criteria for operative and non operative management in 209 patients. J Gastrointest Surg 7. 2003, 970-977.
- Serous cystadenocarcinoma of the pancreas: report of a case and management reflections
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II